January 11, 2021
REGENXBIO Announces Proposed Public Offering Of Common Stock
ROCKVILLE, Md., Jan. 6, 2021 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq:RGNX), a leading clinical-stage biotechnology company seeking…
January 11, 2021
CIT Announces Inaugural Solicitation for the New Commonwealth Commercialization Fund
Richmond, VA, Jan. 07, 2021 (GLOBE NEWSWIRE) -- The Center for Innovative Technology (CIT) announced…
January 11, 2021
Behrman Capital’s Emmes acquires Neox
Headquartered in Prague, Czech Republic, Neox is a CRO with over 150 employees who support…
January 11, 2021
Maxcyte | Myeloid Therapeutics and MaxCyte Enter Clinical and Commercial Licensing Agreement to Advance Myeloid’s Cell Therapy Programs
CAMBRIDGE, MA and GAITHERSBURG, MD, January 11, 2021 — Myeloid Therapeutics, Inc., a company harnessing…
January 11, 2021
Baltimore’s Port Covington Ramps Up After Financing Boost
With more than $650 million in financing in place, vertical construction in excess of 1.1…